Manual Antimicrobial Susceptibility Test Systems
Main Filters
Manual Antimicrobial Susceptibility Test Systems
| BIOMERIEUX SA | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| ETEST® Amikacin (AK) | 0 | - | ||
| ETEST® Amoxicillin (AC) | 0 | - | ||
| ETEST® Amoxicillin/clavulanic acid (2/1) (XL) | 0 | - | ||
| ETEST® Ampicillin (AM) | 0 | - | ||
| ETEST® Ampicillin/sulbactam (2/1) (AB) | 0 | - | ||
| ETEST® Azithromycin (AZ) | 0 | - | ||
| ETEST® Benzylpenicillin (PG) | 0 | - | ||
| ETEST® Benzylpenicillin (PG) | 0 | - | ||
| Etest® CEFACLOR | 0 | - | ||
| ETEST® Cefepime (PM) | 0 | - | ||
| Etest® CEFOTAXIME | 0 | - | ||
| ETEST® Cefotaxime (CT) | 0 | - | ||
| ETEST® Cefoxitin (FX) | 0 | - | ||
| ETEST® Ceftazidime (TZ) | 0 | - | ||
| ETEST® Ceftazidime/Avibactam (CZA) | 0 | - | ||
| ETEST® Ceftriaxone (TX) | 0 | - | ||
| ETEST® Ceftriaxone (TX) | 0 | - | ||
| ETEST® Cefuroxime (XM) | 0 | - | ||
| ETEST® Cephalothin (CE) | 0 | - | ||
| ETEST® Chloramphenicol (CL) | 0 | - | ||
| ETEST® Ciprofloxacin (CI) | 0 | - | ||
| ETEST® Clindamycin (CM) | 0 | - | ||
| ETEST® Daptomycin (DPC) | 0 | - | ||
| Etest® DORIPENEM | 0 | - | ||
| Etest® ERTAPENEM | 0 | - | ||
| ETEST® Erythromycin (EM) | 0 | - | ||
| ETEST® Gentamicin (GM) | 0 | - | ||
| ETEST® Imipenem (IP) | 0 | - | ||
| ETEST® Levofloxacin (LE) | 0 | - | ||
| ETEST® Meropenem (MP) | 0 | - | ||
| ETEST® Metronidazole (MZ) | 0 | - | ||
| ETEST® Minocycline (MC) | 0 | - | ||
| ETEST® Moxifloxacin (MX) | 0 | - | ||
| ETEST® Ofloxacin (OF) | 0 | - | ||
| Etest® OXACILLIN | 0 | - | ||
| ETEST® Oxacillin (OX) | 0 | - | ||
| Etest® PIP/TAZO/CON-4 | 0 | - | ||
| Etest® PIP/TAZO/CON-4 | 0 | - | ||
| Etest® PIPERACILLIN | 0 | - | ||
| ETEST® Piperacillin (PP) | 0 | - | ||
| ETEST® Rifampicin (RI) | 0 | - | ||
| ETEST® Tetracycline (TC) | 0 | - | ||
| ETEST® Tetracycline (TC) | 0 | - | ||
| Etest® TIC/CLAV-CON2 | 0 | - | ||
| ETEST® Ticarcillin/clavulanic acid (TLC) | 0 | - | ||
| Etest® TIGECYCLINE | 0 | - | ||
| Etest® TOBRAMYCIN | 0 | - | ||
| ETEST® Tobramycin (TM) | 0 | - | ||
| ETEST® Trimethoprim/sulfamethoxazole (1/19) (TS) | 0 | - | ||
| ETEST® Vancomycin (VA) | 0 | - | ||
626 Results
Results Per Page
- 50
- 100
- 250
Catalog #
AvailableQty
Starting At
Name
Company Name
Description
0
-
ETEST® Ticarcillin/clavulanic acid (TLC)
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
ETEST® Tetracycline (TC)
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
ETEST® Tobramycin (TM)
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
ETEST® Piperacillin (PP)
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® PIP/TAZO/CON-4
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
ETEST® Oxacillin (OX)
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
ETEST® Ofloxacin (OF)
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
ETEST® Minocycline (MC)
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
ETEST® Meropenem (MP)
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
ETEST® Imipenem (IP)
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
ETEST® Gentamicin (GM)
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
ETEST® Erythromycin (EM)
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
ETEST® Clindamycin (CM)
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
ETEST® Ciprofloxacin (CI)
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
ETEST® Chloramphenicol (CL)
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
ETEST® Cefuroxime (XM)
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
ETEST® Ceftazidime/Avibactam (CZA)
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
ETEST® Ceftazidime (TZ)
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
ETEST® Ceftriaxone (TX)
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
ETEST® Ceftriaxone (TX)
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
ETEST® Cefoxitin (FX)
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
ETEST® Cefotaxime (CT)
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® CEFOTAXIME
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
ETEST® Cefepime (PM)
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® CEFACLOR
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
ETEST® Cephalothin (CE)
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
ETEST® Benzylpenicillin (PG)
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
ETEST® Benzylpenicillin (PG)
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
ETEST® Ampicillin/sulbactam (2/1) (AB)
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
ETEST® Azithromycin (AZ)
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
ETEST® Amikacin (AK)
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
ETEST® Amoxicillin (AC)
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
ETEST® Ampicillin (AM)
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
ETEST® Amoxicillin/clavulanic acid (2/1) (XL)
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® DORIPENEM
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
ETEST® Daptomycin (DPC)
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® TIGECYCLINE
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® ERTAPENEM
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
ETEST® Metronidazole (MZ)
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
ETEST® Moxifloxacin (MX)
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
ETEST® Levofloxacin (LE)
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
ETEST® Rifampicin (RI)
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
ETEST® Vancomycin (VA)
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
ETEST® Trimethoprim/sulfamethoxazole (1/19) (TS)
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® TIC/CLAV-CON2
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
ETEST® Tetracycline (TC)
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® TOBRAMYCIN
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® PIPERACILLIN
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® PIP/TAZO/CON-4
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® OXACILLIN
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
